CIP journal articles
2010
| Phipps D, Noyce PR, Walshe K, Paker D, Ashcroft DM. What factors should you focus on to provide meaningful risk assessments? The Pharmaceutical Journal 2010. 284; 27 March: 312. External link |
2009
| Wagner AC, Noyce PR,Ashcroft DM. What has relaxation of control of entry done for equality of access for patients? The Pharmaceutical Journal 2009. 283; 14 November: 530. External link |
| Wagner A, Hann M, Noyce p, Ashcroft DM. Equity in the distribution of community pharmacies in England: impact of regulatory reform. Journal of Health Services Research & Policy.14:4:243-248. External link |
| Williams SD, Ashcroft DM. Medication errors: How reliable are the severity ratings reported to the National Reporting and Learning System? International Journal for Quality in Health Care 2009; 21: 316-320. External link |
| Phipps DL,Noyce PR,Parker D, Ashcroft DM. Medication safety in community pharmacy: a qualitative study of the sociotechnical context. BMC Health Services Research 2009, 9:158 doi:10.1186/1472-6963-9-158. External link |
| Tully MP, Ashcroft DM, Dornan T, Lewis PJ, Taylor D, Wass V. The causes of and factors associated with prescribing errors in hospital inpatients. Drug Safety 2009; 32(10): 819-836. External link |
| Lewis PJ, Dornan T,Taylor D, Tully MP, Wass V, Ashcroft DM. Prevalence, Incidence and Nature of Prescribing Errors in Hospital Inpatients - A Systematic Review. Drug Safety 2009; 32 (5): 379-389. External link |
| Saad AA, Ashcroft DM, Watson KD, Hyrich KL, Noyce PR, Symmons DPM. Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register. Arthritis Research and Therapy 2009; 11(2): R52. External link |
| Ashcroft DM, Parker D. Development of the Pharmacy Safety Climate Questionnaire: a principal components analysis. Quality & Safety in Health Care 2009;18: 28-81. External link |
2008
| Bradley F, Wagner AC, Elvey R, Noyce PR, Ashcroft DM. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: A multi-method study. Health Policy 2008;88: Issues 2-3: 258-268. External link |
| Elvey R, Ashcroft DM, Noyce P. GP engagement: the key to repeat dispensing? International Journal of Pharmacy Practice 2008; 16: 303-308. External link |
| Bradley F, Elvey R, Ashcroft DM, Hassell K, Kendall J; Sibbald B; Noyce P. The challenge of integrating community pharmacists into the primary health care team: A case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration. Journal of Interprofessional Care, 2008;22,4 387-398. External link |
| Whitton ME, Ashcroft DM, Gonzalez U. Therapeutic interventions for vitiligo. Journal of the American Academy of Dermatology 2008;59:713-7.External link |
| Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: A systematic review of prospective observational studies. Annals of Pharmacotherapy 2008: 42: 1017-1025. External link |
| Elvey R, Ashcroft DM, Noyce P (In press). GP engagement: the key to repeat dispensing? International Journal of Pharmacy Practice. |
| Bradley F, Elvey R, Ashcroft DM, Hassell K, Kendall J, Sibbald B, Noyce P (In press). The challenge of integrating community pharmacists into the primary health care team: a case study of Local Pharmaceutical Services (LPS) pilots and interprofessional collaboration. Journal of Interprofessional Care. |
| Ashcroft DM, Parker D (In press). Development of the Pharmacy Safety Climate Questionnaire: a principal component analysis. Quality and Safety in Health Care. |
| Thornton J, Lunt M, Ashcroft DM, Baildam E, Foster H, Davidson J, Gardner-Medwin J, Beresford M, Symmons D, Thomson W, Elliott R. Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. Rheumatology 2008; 47: 985-990. External link |
| Saad AA, Symmons DPM, Noyce PR, Ashcroft DM. Risks and benefits of TNF-alpha inhibitors in the management of psoriatic arthritis: systematic review and meta-analysis of randomised controlled trials. Journal of Rheumatology 2008; 35: 883-890. External link |
| Halsall D; Ashcroft, D; Noyce, P. Assessing quality in community pharmacy. International Journal of Pharmacy Practice, 2008. 16 (3): 137-148. |
| Thornton J, Ashcroft D, O'Neill T, Elliott R, Adams J, Roberts C, Rooney M, Symmons D. A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management. Health Technology Assessment 2008; 12(3): 1-208. External link |
| Chen LC, Ashcroft DM. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 2008; 48: 236-247 External link |
2007 |
| Ashcroft DM, Chen LC, Garside R, Stein K, Williams HC. Topical pimecrolimus for eczema. Cochrane Database of Systematic Reviews; 2007 (Issue 4). External link |
| Chen LC, Ashcroft DM, Elliott RA. Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study. Pharmacy World and Science 2007; 29: 661-670. External link |
| Seston EM, Ashcroft DM, Griffiths CEM. Balancing the benefits and risks of drug treatment: a stated preference discrete choice experiment with patients with psoriasis. Archives of Dermatology 2007; 143(9): 1175-1179. External link |
| Chen LC, Ashcroft DM. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine. Headache 2007; 47: 1169-1177. External link |
| Mackellar A, Ashcroft DM, Bell D, James DH, Marriott J. Identifying criteria for the assessment of pharmacy students’ communication skills with patients. American Journal of Pharmaceutical Education 2007; 71(3): 50. External link |
| Bradley F, Elvey R, Ashcroft DM, Noyce P. Influence of prescription charges on repeat prescribing in primary care. Journal of Clinical Pharmacy and Therapeutics 2007; 32: 269-275. External link |
| Chen LC, Ashcroft DM. Risk of myocardial infarction associated with selective COX-2 inhibitors: Meta-analysis of randomised controlled trials. Pharmacoepidemiology and Drug Safety. 2007; 16: 762-772. External link |
2006 |
| Ashcroft DM, Cooke J. Retrospective analysis of an online reporting scheme for medication incidents.Pharmacy World and Science 2006; 28: 359-365. External link |
| Chen LC, Ashcroft DM. Do selective Cox-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomised controlled trials. Journal of Clinical Pharmacy and Therapeutics 2006; 31: 565-576. External link |
| Ashcroft DM, Seston E, Griffiths CEM. Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with UK dermatologists. British Journal of Dermatology 2006; 155: 1236-1241 External link |
| Thornton J, Ashcroft DM, Mughal Z, Elliott RA, O’Neill TW, Symmons D. Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis. Archives of Disease in Childhood 2006; 91: 753-761 External link |
| Smith S, Smith GE, Heatlie H, Bashford JNR, Ashcroft DM, Verlander NQ, Duckworth GJ, Mason B, Smyth B, Maxwell S. Reducing variation in antibacterial prescribing rates for “cough/cold” and sore throat between 1993 and 2001: regional analyses using the General Practice Research Database. Public Health 2006; 120: 752-759. External link |
| Ashcroft DM, Hall J. Using portfolios to learn about prescribing: qualitative insights into students’ experiences. Pharmacy Education 2006; 6: 91-95. |
| Elvey R, Bradley F, Ashcroft D, Noyce P. Commissioning services and the new community pharmacy contract: (1) Pharmaceutical needs assessments and uptake of new pharmacy contracts. Pharmaceutical Journal 2006; 277: 161-163. External link |
| Bradley F, Elvey R, Ashcroft D, Noyce P. Commissioning services and the new community pharmacy contract: (2) Drivers, barriers and approaches to commissioning. Pharmaceutical Journal 2006; 277: 189-192. External link |
| Bradley F, Elvey R, Ashcroft D, Noyce P. Commissioning services and the new community pharmacy contract: (3) Uptake of enhanced services. Pharmaceutical Journal 2006; 277: 224-226. External link |
| Elvey R, Bradley F, Ashcroft D, Noyce P. Commissioning services and the new community pharmacy contract: (4) Governance and performance management. Pharmaceutical Journal 2006; 277: 251-253. External link |
| Ashcroft DM, Hall J. Pharmacy students’ attitudes and views about portfolio-based learning: a questionnaire survey. Pharmacy Education 2006; 6: 1-5. |
| Morecroft CW, Ashcroft DM, Noyce P. Repeat dispensing of prescriptions in community pharmacies: a systematic review of the literature. International Journal of Pharmacy Practice 2006; 14: 11-19 |
| Ashcroft DM, Morecroft C, Parker D, Noyce PR. Likelihood of reporting adverse events in community pharmacy: an experimental study. Quality and Safety in Health Care 2006; 15: 48-52. External link |
| Elvey R, Ashcroft D, Noyce P. Repeat dispensing: the benefits for GPs, pharmacists and patients. Prescriber 2006; 17: 12-18. |
| Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. The Cochrane Database of Systematic Reviews; 2006 (Issue 1). External link |
2005 |
| Ashcroft DM, Morecroft C, Parker D, Noyce P. Safety culture assessment in community pharmacy: Development, face validity and feasibility of the Manchester Patient Safety Assessment Framework. Quality and Safety in Health Care 2005: 14(6): 417-421 [1] External link (abstract) [2] Link to MaPSAF tools |
| Fairhurst DA, Ashcroft DM, Griffiths CE. Optimal management of severe plaque form of psoriasis. American Journal of Clinical Dermatology 2005; 6(5): 283-294. External link |
| Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. Health Technology Assessment 2005; 9(29): 1-246. External link |
| Ashcroft DM, Morecroft C, Parker D, Noyce P. Reporting, reflecting on and learning from adverse events in community pharmacy: development and evaluation of an incident reporting form. Pharmaceutical Journal 2005; 274: 615-617. External link |
| Ashcroft DM, Quinlan P, Blenkinsopp A. Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies. Pharmacoepidemiology and Drug Safety 2005; 14: 327-332. External link |
| Kendall J, Sibbald B, Ashcroft D, Bradley F, Elvey R, Hassell K, Noyce P. Role and uptake of local pharmaceutical services contracts in commissioning community pharmacy services. Pharmaceutical Journal 2005; 274: 454-457. External link |
| Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. British Medical Journal 2005; 330: 516-522. External link |
| Hall J, Ashcroft D. Learning about prescribing in the undergraduate pharmacy degree course: the Manchester experience. Pharmaceutical Journal 2005; 274: 799-800. External link |
| Morecroft C, Ashcroft DM, Noyce P. Research governance and pharmacy practice research: a case study. Pharmaceutical Journal 2005; 274: 650-651. External link |
| Elvey R, Ashcroft D, Bradley F, Hassell K, Kendall J, Noyce P, Sibbald B. Setting up local pharmaceutical services: lessons for primary care trusts. Pharmaceutical Journal 2005; 274: 546-548. External link |
| Bradley F, Kendall J, Ashcroft D, Elvey R, Hassell K, Noyce P, Sibbald B. Setting up local pharmaceutical services: lessons for pharmacy contractors. Pharmaceutical Journal 2005; 274: 548-551 External link |
2004 |
| Smith GE, Smith S, Heatlie H, Bashford JNR, Hawker J, Ashcroft D, Millson D, Verlander NQ, Warren R. What has happened to antimicrobial usage in primary care in the since the SMAC report? Description of trends in antimicrobial usage using the General Practice Research Database. Journal of Public Health 2004; 26(4): 359-364. External link |
| Chen LC, Elliott RA, Ashcroft DM. Systematic review of the analgesic efficacy and tolerability of Cox-2 inhibitors in post-operative pain control. Journal of Clinical Pharmacy and Therapeutics 2004; 29: 215-229. External link |
| Ashcroft DM, Millson D. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Pharmacoepidemiology and Drug Safety 2004; 13: 73-82. External link |